Serological testing for SARS-CoV-2 specific antibodies is important for understanding and controlling the pandemic, particularly through epidemiological surveillance. However, there remains an urgent need for well validated and performant serology tests, notably demonstrating very high specificity. In this JCM Accepted Manuscript posted online January 8, 2021, discover the analytical and clinical performance of VIDAS® SARS-CoV-2 IgM and VIDAS® SARS-CoV-2 IgG, two EUA-authorized, automated, qualitative assays.

Journal of Clinical Microbiology
April 9, 2021